Paradeep Phosphates Ltd.
NSE: PARADEEPParadeep Phosphates Ltd.: A 30-second snapshot
Paradeep Phosphates (PARADEEP) is an NSE-listed fertiliser and specialty chemicals company currently priced at 120.46, trading 23% below its 200-DMA of 156.34 and 48% below its 52-week high. FY26 saw reported revenue growth of 29% and net profit growth of approximately 52%, yet over the same 12-month window the stock is down 18%, reflecting a gap between reported earnings momentum and market pricing. The stock carries a debt-to-equity of 87.0 with a rising debt trend, a net profit margin of 4.97%, and a quality score of 41/100.
P/E
12.6
Forward P/E
10.1
ROE
—
Debt / Equity
87.04
Profit Margin
+5.0%
Div. Yield
+0.8%
5Y ROE > 15%
1/5
5Y FCF > 0
2/5
Quality
48/100
News
8 headlines · 6 positive · 1 negative
Paradeep Phosphates Limited Reports 29% Revenue Growth in FY26 - Global Agriculture
Global Agriculture
PARADEEP: FY26 saw 29% revenue and 52% net profit growth, with major capacity and product expansions - TradingView
TradingView
Paradeep Phosphates reports strong FY26 performance; revenue up 29 per cent, PAT surges 52 per cent - Agro Spectrum India
Agro Spectrum India
Paradeep Phosphates Stock Skyrockets 7% After Reporting 50% Increase in PAT YoY - Trade Brains
Trade Brains
Paradeep Phosphates Q4 Profit Dips; FY26 Surges 52% - Rediff MoneyWiz
Rediff MoneyWiz
Recent context
- ·Multiple sources reported FY26 full-year results in May 2026: revenue up 29%, PAT up approximately 52%, attributed in part to capacity expansion and the MCFL merger; the stock moved approximately 7% on results day per Trade Brains.
- ·One headline noted Q4 profit dipped on a standalone quarter basis even as full-year profit surged 52%, pointing to uneven quarterly distribution of earnings within the fiscal year.
- ·The stock sits just above the nearest technical support at 105.78, with resistance levels clustered at 122.2, 138.48, and 141.25; RSI of 43.3 is in neutral territory with no momentum extreme in either direction.
Strengths
- +FY26 revenue growth of 29% and reported net profit growth of approximately 52% represent the strongest headline earnings print in recent periods, consistent with multiple independent sources.
- +Forward PE of 10.1x compares to sector peers Pidilite (61.0x), SRF (43.5x), Solar Industries (93.5x), and Coromandel (28.2x) — PARADEEP is ranked 1st of 6 tracked peers on PE, indicating the current price implies a lower earnings multiple than any comparable in the peer set.
- +Trailing PE of 12.6x and a dividend yield of 0.83% add incremental return for holders in a low-multiple context.
- +Quality score of 41/100 ranks 3rd of 6 among sector peers tracked (Pidilite 66, Solar 61, SRF 41), placing PARADEEP in the middle tier despite fertiliser sector margin pressures.
Weaknesses
- −Debt-to-equity of 87.0 is the most elevated fundamental risk flag; the debt trend is rising, FCF was positive in only 2 of the available years, and ROE data is absent — together these limit visibility into the company's ability to service and reduce leverage.
- −5-year earnings growth of -9.8% against 5-year revenue growth of +40% reflects sustained failure to convert top-line scale into bottom-line growth over the measurement window; profit margin of 4.97% is thin by Chemicals sector standards.
- −Price has declined 18% over 12 months and sits 48.4% below its 52-week high; the stock has been below its 200-DMA of 156.34 for an extended period, with the 50-DMA (119.68) only marginally below current price.
- −ROE crossed the 15% threshold in only 1 of the available years, and the persistence consistency score of 40/100 indicates earnings quality has been uneven across the available history.
Open questions
- ?Does the 52% FY26 PAT growth reflect a durable improvement in fertiliser realisations and product mix, or is it primarily a one-time benefit from the MCFL merger consolidation?
- ?At a D/E of 87.0 with a rising debt trend, how does the company's interest coverage ratio trend over the last 3 years, and what proportion of FCF is consumed by debt service?
- ?Revenue has grown 40% over 5 years while earnings contracted 9.8% — what has driven the margin compression, and are those cost pressures (raw material, subsidy lag, logistics) structural or cyclical?
- ?With the forward PE at 10.1x versus sector peers ranging from 28x to 93x, what would need to change in earnings trajectory or balance sheet health for the valuation gap to narrow?
Peer comparison: Chemicals
Ranks 3 of 6 on quality| Symbol | Name | P/E | ROE | Quality |
|---|---|---|---|---|
| PARADEEP | Paradeep Phosphates Ltd.You're viewing | 12.6 | — | 41 |
| Industry avg | across 5 peers | 51.7 | +21.1% | 45 |
| PIDILITIND | Pidilite Industries Ltd. | 61.0 | +23.5% | 66 |
| SOLARINDS | Solar Industries India Ltd. | 93.5 | +31.3% | 61 |
| SRF | SRF Ltd. | 43.5 | +13.8% | 41 |
| COROMANDEL | Coromandel International Ltd. | 28.2 | +15.6% | 30 |
| PIIND | PI Industries Ltd. | 32.6 | — | 25 |
Technical state
Current price
₹120.46
SMA 50
₹119.68
SMA 200
₹156.34
RSI (14)
43.3 (neutral)
From 52w high
-48.4%
1Y return
-18.0%
3M return
-2.0%
50-DMA
Above
200-DMA
Below
Algorithmic support levels
Algorithmic resistance levels
Risk flags
- highDebt-to-equity of 87.0 with a rising debt trend and FCF positive in only 2 of available years; ROE data is absent, making independent solvency assessment difficult. D/E of 87.0 is substantially above the Chemicals sector peers tracked (Pidilite, SRF, Coromandel).
- high5-year earnings growth of -9.8% against 5-year revenue growth of +40% indicates sustained margin erosion over the measurement period. Net profit margin of 4.97% and quality score of 41/100 reflect thin and inconsistent profitability; ROE crossed 15% in only 1 of the available years.
- mediumCurrent price of 120.46 is 23.0% below the 200-DMA of 156.34 and 48.4% below the 52-week high. Stock is down 18.0% over 12 months and has been trading below its 200-DMA for an extended period.
- lowAnalyst coverage is sparse at 3 analysts. Mean rating of 2.33 on a 1-5 scale (lower = more constructive) with only 3 analysts tracked limits the weight any consensus inference can carry.
Cross-section contradictions
- FY26 full-year revenue grew 29% and net profit reportedly surged 52% (per multiple news sources), yet the stock is down 18% over 12 months and 48.4% below its 52-week high — the market appears to be discounting reported earnings growth, possibly due to elevated debt levels or merger-related earnings quality concerns.
- Revenue grew 40% over 5 years while earnings shrank 9.8% over the same period, pointing to a structural disconnect between top-line scale and bottom-line conversion that persisted through the measurement window.
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.
Fundamentals & technicals: refreshed 25 Jun 2026 · refreshed daily at 01:00 IST
AI synthesis (narrative, snapshot, strengths/weaknesses, peer ranking): generated 17 May 2026 · rotates through NIFTY 500 every ~5 days